Semmelweis University
- Country
- 🇭🇺Hungary
- Ownership
- Private, Subsidiary
- Established
- 1769-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.sote.hu
Clinical Trials
120
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (85 trials with phase data)• Click on a phase to view related trials
Adaptation of Pediatric Speech Audiometry Tests Into Other Languages
- Conditions
- Hearing LossScreening
- First Posted Date
- 2025-09-05
- Last Posted Date
- 2025-09-05
- Lead Sponsor
- Semmelweis University
- Target Recruit Count
- 120
- Registration Number
- NCT07156825
- Locations
- 🇭🇺
Semmelweis University, Budapest, Hungary
Shoulder Injury Prevention in Adolescent Handball Players Based on Scandinavian Protocols
- Conditions
- Injury PreventionShoulder Injuries
- First Posted Date
- 2025-08-28
- Last Posted Date
- 2025-09-08
- Lead Sponsor
- Semmelweis University
- Target Recruit Count
- 137
- Registration Number
- NCT07146243
- Locations
- 🇭🇺
FTC Handball Academy, Budapest, Hungary
Speech of Kids After Neonatal Encephalopathy
- Conditions
- HIE - Hypoxic - Ischemic EncephalopathyLanguage DelayAutismADHD - Attention Deficit Disorder With HyperactivitySpecific Language ImpairmentIntellectual Developmental Disorder
- First Posted Date
- 2025-08-22
- Last Posted Date
- 2025-08-22
- Lead Sponsor
- Semmelweis University
- Target Recruit Count
- 93
- Registration Number
- NCT07136636
- Locations
- 🇭🇺
Semmelweis University, Budapest, Hungary
Freeze-dried Bone Allograft vs Autologous Bone Blocks in the Lateral Augmentation of the Jaws
- Conditions
- Edentulous Alveolar RidgeEdentulous Alveolar Ridge Atrophy
- First Posted Date
- 2025-08-05
- Last Posted Date
- 2025-09-04
- Lead Sponsor
- Semmelweis University
- Target Recruit Count
- 30
- Registration Number
- NCT07104370
Cardiovascular Risk in Children With Chronic Conditions Study
- Conditions
- Kidney TransplantFamilial HypercholesterolaemiaChronic Kidney DiseaseKawasaki DiseaseLiver TransplantObesity and OverweightHypertensionCoarctation of AortaBone Marrow TransplantCancer (Solid Tumors)
- First Posted Date
- 2025-07-25
- Last Posted Date
- 2025-08-08
- Lead Sponsor
- Semmelweis University
- Target Recruit Count
- 300
- Registration Number
- NCT07086989
- Locations
- 🇭🇺
Semmelweis University, Institute of Preventive Medicine and Public Health, Budapest, Hungary
🇭🇺Semmelweis University, Department of Surgery, Transplantation and Gastroenterology, Budapest, Hungary
🇭🇺Semmelweis University, Pediatric Center, Budapest, Hungary
- Prev
- 1
- 2
- 3
- 4
- 5
- 23
- Next
News
Algernon NeuroScience Launches Phase 2a Trial of DMT for Stroke Recovery with Leading Neurologist
Algernon NeuroScience appoints Dr. Sándor Nardai to lead a groundbreaking Phase 2a clinical trial investigating DMT as a potential stroke recovery treatment, set to begin in Q3 2025.